Acute Tox - Logo

 

Partners

 

Part. nu.

Scientific team leader

Organisation/ Institution

Contact

1

Dr. Leila Risteli

Research and Innovation Services, University of Oulu, FIN

leila.risteli@oulu.fi

2

Dr. Cecilia Clemedson

Expertrådet Environmental Competence Ltd, SE

cecilia.clemedson@expertradet.se

3

Prof. José Castell
Dr Maria Jose Gomez-Lechon

University Hospital La Fe, Valencia, ES

jose.castell@uv.es 

gomez_mjo@gva.es

4

Dr. Pilar Prieto

Dr. Thomas Cole

Dr. Sandra Coecke

Dr. Agnieszka Kinsner

Institute for Health and Consumer Protection, ECVAM, Joint Research Centre, I

maria.prieto-pilar@jrc.it

 

5

Dr. Joan-Albert Vericat

NeuroPharma, Madrid, ES

jvericat@neuropharma.es

6

Dr. Bas Blaauboer

Institute of Risk Assessment Sciences, Utrecht University, NL

b.blaauboer@uu.nl

7

Dr. Per Garberg

Biovitrum, Stockholm, SE

per.garberg@biovitrum.com

 

8

Dr. Richard Clothier

University of Nottingham, Nottingham, UK

       

9

Prof. José-Enrique O´Connor

The University of Valencia, Department of Biochemistry and Molecular Biology, ES

jose.castell@uv.es

10

Dr. Laurence Lafanechere

Centre de Griblage de Molécules Bio-actives, Grenoble, FR

laurence.lafanechere@cea.fr

11

Dr. Beatriz Albella

CIEMAT, Madrid, ES

beatriz.albella@ciemat.es

12

Prof. Pedro Buc Calderon

Universite Catholoique de Louvain, B

calderon@pmnt.ucl.ac.be

13

Dr. Cristina Sunol

Dr Nuria Campillo

Consejo Superior de Investigaciones Cientificas, ES

csenqi@iibb.csic.es

14

Dr. Thaly Lakhanisky

Institute of Public Health, Lab. Biochemical Toxicology, B

thaly.lakhanisky@iph.fgov.be

15

Dr. Myriam Fabre

Advanced In Vitro Cell Technologies, S.L.,

C/ Baldiri i Reixac, Barcelona, ES

myriam.f@advancell.net

16

Dr. Anna Forsby

Dept. of Neurochemistry, Stockholm University, SE

annaf@neurochem.su.se

17

Dr. Hans Juergen Ahr

Bayer AG Elberfeld, D

hans-juergen.ahr@bayerhealthcare.com

18

Prof. Gabrielle Hawksworth

Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, UK

g.m.hawksworth@abdn.ac.uk

19

Prof. Robert Rudowski

Department of Medical Informatics, Medical University of Warsaw, PL

Robert.Rudowski@amwaw.edu.pl

20

Prof. Paul Honegger

Institute of Physiology, University of Lausanne, CH

paul.honegger@unil.ch

21

Prof. Ron Kooijman

Department of Pharmacology, Free University of Brussels, B

ron.kooijman@vub.ac.be

23

Dr. Mónica Betanzos

FUNDACIÓN GAIKER, Zamudio, ES

betanzos@gaiker.es

24

Dr. Christina Rudén

Royal Institute of Technology, Stockholm, SE

cr@infra.kth.se

25

Prof. Michael P. Ryan

Department of Pharmacology, University of College Dublin, IE

michael.p.ryan@ucd.ie

26

Prof. Michael Sjöström

Dept. of Chemistry, Chemometric group, Umeå University, SE

michael.sjostrom@chem.umu.se

27

Dr. Annalaura Stammati

Istituto Superiore di Sanità, Roma, I

annalaura.stammati@iss.it

28

Prof. Bruno Stieger

University Hospital, Div. Clinical Pharmacology & Toxicology, Zürich, CH

bstieger@kpt.unizh.ch

29

Dr. Inge Mangelsdorf

Fraunhofer, Institute of Toxicology and Experimental Medicine, Hannover, D

inge.mangelsdorf@item.fraunhofer.de

31

Prof. Jitka Ulrichová

Institute of Medical Chemistry and Biochemistry, Faculty of Medicin, Palacky University, Olomouc, CZ

ulricho@tunw.upol.cz

33

Prof. Albrecht Wendel

Dr. Marcel Leist

STZ InPuT, Konstanz, D

Albrecht.Wendel@uni-konstanz.de

marcel.leist@uni-konstanz.de

34

Prof. Per Artursson

Deparment of Pharmacy, Uppsala University, Uppsala, SE

Per.Artursson@farmaci.uu.se

35

Prof. Roméo Cecchelli

University of Artois, Institut Pasteur de Lille, Lens, FR

romeo.cecchelli@univ-artois.fr

36

Dr. Ada Kolman

Swedish Fund for Research without Animal Experiments, Stockholm, SE

kolman@bredband.net

37

Prof. Victor Rimbau

Department of Pharmacology and Therapeutical Chemistry, University of Barcelona, ES

rimbau@ub.edu